TORONTO and NEW YORK, Oct. 10,
2017 /CNW/ - AcuityAds Holdings Inc. (TSXV:AT)
("AcuityAds" or "Company"), a technology leader that provides
targeted digital media solutions enabling advertisers to connect
intelligently with audiences across video, mobile, social and
online display campaigns, today announced that it received an order
from a global pharmaceutical company totaling $750,000 CDN. This global pharmaceutical
company will be running multiple digital advertising campaigns
throughout the U.S. in the fourth quarter in support of a brand
re-launch for one of their over-the-counter medicines.
AcuityAds acquired 140 Proof for its social signal-based mobile
offering and acquired Visible Measures for its analytics-led video
offering. The integrated company enables its sales force to
provide a more powerful holistic solution and engage in expanded
conversations with brands to capture a greater share of their
digital advertising spend.
"This win highlights the expanded value proposition that we can
offer marketers looking to garner real returns and those seeking a
greater share of audience attention from their advertising
initiatives," stated Tal Hayek, CEO
of AcuityAds. "It also validates that we are seeing a
significant increase in the average order size."
Additionally, the Company is pleased to announce that it was
recently recognized as the fifth fastest growing Canadian software
company in Canada and ranked #18
overall on the 2017 PROFIT 500 Ranking of Canada's Fastest Growing Companies.
About AcuityAds:
AcuityAds is a technology company that enables marketers to
connect intelligently with their most meaningful audiences through
digital media. A Self-Serve programmatic marketing platform,
powered by machine learning, is at the core of our business. This
is accompanied by strategic digital advertising solutions that
cater to social, mobile and video-specific needs. AcuityAds
empowers marketers by offering transparency on costs and brand
safety, and real-time reporting and analytics, bringing
accountability to programmatic advertising to deliver business
results.
AcuityAds is headquartered in Toronto,
Canada with sales offices in New
York City, Boston,
Chicago, Los Angeles, San
Francisco, San Diego,
Dallas, Vancouver, Calgary, Montreal and London,
England. For more information, visit AcuityAds.com.
Disclaimer in regards to Forward-looking
Statements
Certain statements included herein constitute "forward-looking
statements" within the meaning of applicable securities laws.
Forward-looking statements are necessarily based upon a number of
estimates and assumptions that, while considered reasonable by
management at this time, are inherently subject to significant
business, economic and competitive uncertainties and contingencies.
Investors are cautioned not to put undue reliance on
forward-looking statements. Except as required by law, AcuityAds
does not intend, and undertakes no obligation, to update any
forward-looking statements to reflect, in particular, new
information or future events. The Company's client that has
been mentioned in this press release has the right to exercise an
out clause right at any time during the advertising campaign.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE AcuityAds Inc.